Published in Cancer Weekly, September 12th, 2006
Lynch also has been appointed to the audit committee of the board of directors of each company.
From 2001 until 2005, Lynch was employed by Imclone Systems Incorporated, a publicly traded biotechnology company, serving as its chief financial officer from 2001 until 2003 and as its chief executive officer and a member of its board of directors from 2003 until 2005. Prior to that time, he served as chief financial officer of Derby Cycle Corporation, a designer, manufacturer and marketer of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.